We are live on ! Find out more
PGP

Prescott General Partners Portfolio holdings

AUM $1.37B
1-Year Est. Return 23.81%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+23.81%
3 Year Est. Return
+67.15%
5 Year Est. Return
+9.62%
10 Year Est. Return
+525.75%
AUM
$2.92B
AUM Growth
-$44M
Cap. Flow
-$16.1M
Cap. Flow %
-0.55%
Top 10 Hldgs %
99.93%
Holding
16
New
2
Increased
2
Reduced
2
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 57.29%
2 Consumer Discretionary 24.86%
3 Industrials 11.37%
4 Communication Services 4.73%
5 Healthcare 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACC icon
1
Credit Acceptance
CACC
$5.93B
$1.17B 40.17%
1,707,005
W icon
2
Wayfair
W
$11.5B
$726M 24.86%
3,823,239
WRLD icon
3
World Acceptance Corp
WRLD
$837M
$500M 17.11%
2,037,495
CMPR icon
4
Cimpress
CMPR
$2.38B
$280M 9.57%
3,906,492
YELP icon
5
Yelp
YELP
$1.46B
$138M 4.73%
3,811,985
GIC icon
6
Global Industrial
GIC
$1.36B
$52.5M 1.8%
1,282,421
-13,956
-1% -$572K
VAPO
7
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$36.5M 1.25%
220,467
-99,188
-31% -$17.2M
ME
8
DELISTED
23andMe Holding Co
ME
$7.53M 0.26%
56,519
LCTX icon
9
Lineage Cell Therapeutics
LCTX
$272M
$4.54M 0.16%
1,851,851
LMDX
10
DELISTED
LumiraDx Limited Common Shares
LMDX
$842K 0.03%
94,474
+45,000
+91% +$401K
HUMA icon
11
Humacyte
HUMA
$177M
$580K 0.02%
+80,000
New +$791K
SKIN icon
12
SkinHealth Systems
SKIN
$87.6M
$483K 0.02%
20,000
COUR icon
13
Coursera
COUR
$1.48B
$415K 0.01%
17,000
+7,000
+70% +$213K
SANA icon
14
Sana Biotechnology
SANA
$868M
$313K 0.01%
+20,199
New +$389K
SER icon
15
Serina Therapeutics
SER
$31.3M
$202K 0.01%
5,265
HIPO icon
16
Hippo Holdings
HIPO
$827M
-1,600
Closed -$187K

Similar funds

Prescott General Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Prescott General Partners held 16 positions worth $2.92B, down 1.5% from $2.97B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Prescott General Partners's Q4 2021 filing shows 2 new, 2 increased, 2 reduced and 1 closed positions. Its largest new stake was Humacyte: 80,000 shares worth $580K. The largest sale was Vapotherm, Inc. Common Stock, an estimated $17.2M.

By sector, the portfolio is most concentrated in Financials at 57% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Prescott General Partners's largest Q4 2021 buy was Humacyte: 80,000 shares worth $580K.
  • Prescott General Partners added most to LumiraDx Limited Common Shares in Q4 2021, an estimated $401K increase.
  • Prescott General Partners's biggest Q4 2021 reduction was Vapotherm, Inc. Common Stock, cutting an estimated $17.2M.
  • Prescott General Partners fully exited Hippo Holdings in Q4 2021, selling an estimated $187K.
  • Prescott General Partners's ten largest holdings make up 100% of its $2.92B portfolio in Q4 2021.
  • Prescott General Partners opened 2 new positions and closed 1 in Q4 2021.
  • Prescott General Partners's portfolio value fell 1.5% quarter-over-quarter to $2.92B.

Based on Prescott General Partners's 13F filing for Q4 2021, filed 14 Feb 2022.